Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Carbone

Showing results (131-140 of 227) with videos related to

Pageof 23
Sort By:
Diabetes Technology & Therapeutics|April 20, 2012
Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
Canadian Journal of Physiology and Pharmacology|August 30, 2013
Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapyGiuseppe Derosa, Arrigo F G Cicero, Ivano G Franzetti, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|November 17, 2025
Tracking Glucose Trends, Unveiling Clinical Patterns: Insights From Continuous Glucose Monitoring in Patients at the Extreme of BMI and Eating Disorders PsychopathologyMarianna Rania, Concetta Irace, Raffaella Sacco, et al.
Comprehensive Psychiatry|May 8, 2024
Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophreniaRenato de Filippis, Matteo Aloi, Marco Tullio Liuzza, et al.
Journal of Eating Disorders|April 19, 2026
Disentangling food addiction-related symptom profiles in anorexia nervosa: a latent class analysis and clinical implicationsMatteo Aloi, Marianna Rania, Elvira Anna Carbone, et al.
Bioorganic Chemistry|May 1, 2025
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agentsChiara Vagaggini, Pasqualina D'Ursi, Federica Poggialini, et al.
European Journal of Medicinal Chemistry|September 16, 2018
Synthesis of 5H-pyrido[3,2-b]pyrrolizin-5-one tripentone analogs with antitumor activityBarbara Parrino, Salviana Ullo, Alessandro Attanzio, et al.
Schizophrenia (Heidelberg, Germany)|October 18, 2024
Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salienceMatteo Aloi, Renato de Filippis, Elvira Anna Carbone, et al.
Diabetes Research and Clinical Practice|June 12, 2012
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Anna Carbone, Ivano Franzetti, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
Pageof 23

Showing results (131-140 of 227) with videos related to

Sort By:
Pageof 23
Diabetes Technology & Therapeutics|April 20, 2012
Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
Canadian Journal of Physiology and Pharmacology|August 30, 2013
Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapyGiuseppe Derosa, Arrigo F G Cicero, Ivano G Franzetti, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|November 17, 2025
Tracking Glucose Trends, Unveiling Clinical Patterns: Insights From Continuous Glucose Monitoring in Patients at the Extreme of BMI and Eating Disorders PsychopathologyMarianna Rania, Concetta Irace, Raffaella Sacco, et al.
Comprehensive Psychiatry|May 8, 2024
Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophreniaRenato de Filippis, Matteo Aloi, Marco Tullio Liuzza, et al.
Journal of Eating Disorders|April 19, 2026
Disentangling food addiction-related symptom profiles in anorexia nervosa: a latent class analysis and clinical implicationsMatteo Aloi, Marianna Rania, Elvira Anna Carbone, et al.
Bioorganic Chemistry|May 1, 2025
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agentsChiara Vagaggini, Pasqualina D'Ursi, Federica Poggialini, et al.
European Journal of Medicinal Chemistry|September 16, 2018
Synthesis of 5H-pyrido[3,2-b]pyrrolizin-5-one tripentone analogs with antitumor activityBarbara Parrino, Salviana Ullo, Alessandro Attanzio, et al.
Schizophrenia (Heidelberg, Germany)|October 18, 2024
Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salienceMatteo Aloi, Renato de Filippis, Elvira Anna Carbone, et al.
Diabetes Research and Clinical Practice|June 12, 2012
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Anna Carbone, Ivano Franzetti, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-<i>d</i>]pyrimidine Derivative SI388 Active as Src InhibitorClaudia Contadini, Claudia Cirotti, Anna Carbone, et al.
Pageof 23